GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 98 filers reported holding GOSSAMER BIO INC in Q1 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $9,388 | -79.0% | 7,451 | -63.8% | 0.00% | – |
Q4 2022 | $44,627 | -82.2% | 20,566 | -2.0% | 0.00% | – |
Q3 2022 | $251,000 | +67.3% | 20,976 | +17.2% | 0.00% | – |
Q2 2022 | $150,000 | -3.8% | 17,901 | -0.7% | 0.00% | – |
Q1 2022 | $156,000 | -21.6% | 18,027 | +2.7% | 0.00% | – |
Q4 2021 | $199,000 | -11.6% | 17,553 | -1.6% | 0.00% | – |
Q3 2021 | $225,000 | +257.1% | 17,838 | +127.5% | 0.00% | – |
Q2 2021 | $63,000 | -20.3% | 7,841 | -7.4% | 0.00% | – |
Q1 2021 | $79,000 | -6.0% | 8,465 | -2.4% | 0.00% | – |
Q4 2020 | $84,000 | -21.5% | 8,677 | 0.0% | 0.00% | – |
Q3 2020 | $107,000 | -18.9% | 8,677 | -14.3% | 0.00% | – |
Q2 2020 | $132,000 | +83.3% | 10,121 | +42.0% | 0.00% | – |
Q1 2020 | $72,000 | -48.9% | 7,127 | -21.5% | 0.00% | – |
Q4 2019 | $141,000 | +2.9% | 9,079 | +11.8% | 0.00% | – |
Q3 2019 | $137,000 | +42.7% | 8,123 | +87.9% | 0.00% | – |
Q2 2019 | $96,000 | +152.6% | 4,324 | +147.5% | 0.00% | – |
Q1 2019 | $38,000 | – | 1,747 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |